Stable Non-Competitive DPP-IV Inhibitory Hexapeptide from Parkia timoriana Seeds: A Candidate for Functional Food Development in Type 2 Diabetes
Processes · 26.09.2025 · 13 (10) · 3079
DOI: 10.3390/pr13103079 ↗Kurz gefasst
Fachartikel in der Zeitschrift Processes, online erschienen am 26.09.2025. Verfasst von Sakinah Hilya Abida und 5 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science and Technology Council, Taiwan.
Themen: Diabetes mellitus
Abstract (Originalsprache)
The tree bean (Parkia timoriana), an underutilized legume valued for its nutritional profile, represents a potential source of bioactive peptides for diabetes management. To our knowledge, this is the first study to identify and characterize DPP-IV inhibitory peptides derived from tree bean seed protein hydrolysates. The tree bean proteins were digested with trypsin, thermolysin, chymotrypsin, pepsin, and simulated gastrointestinal (SGI) enzymes, among which SGI hydrolysis yielded the highest degree of hydrolysis (14%) and strongest DPP-IV inhibitory activity (IC50 = 1289 ± 58 µg/mL). Guided by DPP-IV inhibitory assays, sequential fractionation using strong cation exchange and RP-HPLC yielded the most potent fraction, H5, with an IC50 of 949 ± 50 µg/mL. After peptide identification and synthesis, APLGPF (AF6) emerged as the most potent inhibitor, with an IC50 of 396 ± 18 µM. Enzyme kinetics revealed a non-competitive inhibition mechanism, corroborated by molecular docking, which indicated binding at an allosteric site of DPP-IV. Furthermore, AF6 remained stable under simulated gastrointestinal digestion and enzymatic exposure, highlighting its resistance to proteolysis. Taken together, these findings highlight P. timoriana as an underexplored source of peptides with DPP-IV inhibitory activity and identify AF6 as a promising lead for developing functional foods or nutraceuticals aimed at type 2 diabetes management.
Förderung
- National Science and Technology Council, Taiwan
Zitieren
APA
Abida, S. H., Sutopo, C. C. Y., Hung, W., Nong, N. T. P., Mahatmanto, T., & Hsu, J. (2025). Stable Non-Competitive DPP-IV Inhibitory Hexapeptide from Parkia timoriana Seeds: A Candidate for Functional Food Development in Type 2 Diabetes. Processes, 13(10), 3079. https://doi.org/10.3390/pr13103079
Vancouver
Abida SH, Sutopo CCY, Hung W, Nong NTP, Mahatmanto T, Hsu J. Stable Non-Competitive DPP-IV Inhibitory Hexapeptide from Parkia timoriana Seeds: A Candidate for Functional Food Development in Type 2 Diabetes. Processes. 2025;13(10):3079. doi:10.3390/pr13103079
BibTeX
@article{Abida2025,
author = {Abida, Sakinah Hilya and Sutopo, Christoper Caesar Yudho and Hung, Wei-Ting and Nong, Nhung Thi Phuong and Mahatmanto, Tunjung and Hsu, Jue-Liang},
title = {Stable Non-Competitive DPP-IV Inhibitory Hexapeptide from Parkia timoriana Seeds: A Candidate for Functional Food Development in Type 2 Diabetes},
journal = {Processes},
year = {2025},
volume = {13},
number = {10},
pages = {3079},
doi = {10.3390/pr13103079}
}
EUVIMED